ABT241129C117000
- 2.10
- -0.36-14.63%
Abbott Laboratories Newsroom
Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Wednesday Ends With Index Decline | Wall Street Today
'Bunker' and 'Booster' Stocks in the U.S. – Which Would Perform Better in a Downturn Vs. Upturn?
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
ABT Stock Benefits From First Patient Procedures With TAVI System
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Judge Denies Abbott Request for Retrial, Lower Damages in $500M Baby Formula Case
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to Its Board of Directors
Express News | InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to Its Board of Directors
TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $130
Strategic Initiatives and Innovations Drive Buy Rating for Abbott Laboratories
Protein Supplements Market Global Forecast Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, Herbalife, Nestle, Simply Good Foods, WK Kellogg, PepsiCo, and Glanbia
Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed
S&P 500, Dow Hit Records Right After Open | Live Stock
Abbott Tests New Balloon-Expandable TAVI System for Aortic Stenosis, Launches First Patient Procedures With Investigational TAVI Device
Express News | Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable Tavi System to Treat Aortic Stenosis
Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
Abbott Laboratories (NYSE:ABT) Is Largely Controlled by Institutional Shareholders Who Own 78% of the Company
WHO Extends Mpox Emergency; Canada Reports First Clade I Case